TIGIT and neoplasm: In our previous studies, we identified molecular markers in tumour cells and explored metabolic alterations in cancer‐associated fibroblasts and macrophages in HGSOC, as well as novel therapeutic targets such as TIGIT+ T cells13 and S100A9+ tumour cells.14